Nanosonics Limited announced the appointment of Dr. Tracey Batten as a Non-executive Director of Nanosonics effective 26 September 2023. Dr. Batten brings to Nanosonics a wealth of experience in the healthcare sector gained in both non-executive and executive roles, as well as medical practitioner and clinical roles, over more than 30 years. During her executive career, Dr. Batten was Group CEO of Imperial College Healthcare NHS Trust in the United Kingdom, Group CEO of St Vincent's Health Australia, CEO of Eastern Health, CEO of Dental Health Services Victoria and held various other clinical and medical leadership roles.

Dr. Batten holds a Bachelor of Medicine/Bachelor of Surgery from the University of Melbourne, a Master of Health Administration from the University of New South Wales, and an MBA from Harvard Business School. Dr. Batten is currently a non-executive director of Medibank Private Ltd, the EBOS Group Limited, the Accident Compensation Corporation and the National Institute of Water and Atmospheric Research. In addition, Dr. Batten was previously non-executive director of Abano Healthcare Group Ltd. and various other healthcare related research institutes, charities and industry and government bodies.